CA Intermediate · Advanced Accounting · AS 5 Net Profit or Loss for the Period, Prior Period Items and Changes in Accounting Policies
Rohan Pharma Ltd. had been depreciating a plant of cost ₹10,00,000 (residual value nil, 10-year life) on straight line basis. At the start of year 5, after four years' depreciation, the remaining useful life was reassessed as 3 years instead of 6 years. What depreciation should be charged for year 5, and how is the change treated under AS 5?
Depreciation for year 5 is ₹2,00,000, because the book value of ₹6,00,000 after four years is spread over the revised three remaining years. Revising useful life is a change in accounting estimate, applied prospectively, not a policy change or prior period item.
- A₹2,00,000, as a change in accounting estimate affecting current and future periodsCorrect
- B₹1,00,000, as a change in accounting policy with retrospective restatement
- C₹2,00,000, as a prior period item
- D₹3,00,000, as an extraordinary item
Explanation
Accumulated depreciation after 4 years is 4 x 1,00,000 = ₹4,00,000, so book value is ₹6,00,000. Spread over the revised 3 years, depreciation is ₹2,00,000 a year. A revision of useful life is a change in estimate, recognised prospectively in the current and future periods.
Did you get it right without looking?
One question tells you little. A timed set on AS 5 Net Profit or Loss for the Period, Prior Period Items and Changes in Accounting Policies shows your real accuracy, how long you take and where you lose marks.
More AS 5 Net Profit or Loss for the Period, Prior Period Items and Changes in Accounting Policies questions
- Anand Engineering Ltd. changed its cost formula for inventory from FIFO to weighted average in 2025-26, a change required to make its financ…
- Meera Engineering Ltd. depreciated machinery costing Rs 10,00,000 at 10% on written down value. Its useful life estimate was revised at the …
- Sundaram Textiles Ltd. discovered in 2025-26 that the closing inventory at 31 March 2025 had been overstated by Rs 4,00,000 because of a cou…
- Gupta Pharma Ltd. reports profit from ordinary activities of Rs 12,00,000 for 2025-26 before the following items: (i) a prior period expense…
- Meera Pharma Ltd. adopted a new accounting policy in 2025-26 for a transaction type that had never occurred before. Which statement is corre…
- Sagar Textiles Ltd. discovered in the current year that closing stock at the end of the previous year had been overstated by Rs 4,00,000 bec…